GN unveils ReSound Vivia, the world’s smallest AI-powered hearing aid

GN, a global leader in hearing innovation, has unveiled its most intelligent hearing portfolio yet, headlined by ReSound Vivia, the world’s smallest AI-powered hearing aid. This groundbreaking device delivers unparalleled speech clarity, intelligent noise reduction, and all-day comfort without compromising on size or battery life.

AI That Thinks Like the Human Brain

At the core of ReSound Vivia is GN’s unique approach to artificial intelligence, designed to mimic the brain’s natural ability to process sound. Unlike traditional hearing aids that amplify all sounds equally, ReSound Vivia’s Intelligent Focus technology enhances the sounds that matter most—particularly speech—based on the user’s head movements and line of sight. This results in a seamless and natural listening experience, even in challenging noisy environments like busy restaurants or crowded events.

Unmatched Speech Clarity With Deep Neural Networks

ReSound Vivia is powered by a dedicated Deep Neural Network (DNN) chip, which processes speech and background noise 17 times more efficiently than traditional hearing aids. Trained on 13.5 million spoken sentences in multiple languages, the DNN enables Vivia to perform 4.9 trillion operations per day, ensuring crystal-clear speech and significantly reduced background noise.

Studies confirm that ReSound Vivia delivers the world’s best hearing-in-noise experience, with 64% of users reporting improved speech understanding compared to other AI-powered hearing aids.

Small but Powerful: The Ultimate in Discreet Hearing Technology

Despite its advanced capabilities, ReSound Vivia is the world’s smallest AI hearing aid. The microRIE model offers 30 hours of battery life on a single charge, ensuring all-day wearability without interruption. Even with frequent Bluetooth streaming and Intelligent Focus activation, users can expect up to 20 hours of use per charge.

Expanding Accessibility With ReSound Savi

In addition to ReSound Vivia, GN has also introduced ReSound Savi, an essential hearing aid range featuring Bluetooth LE Audio and Auracast broadcast audio. This enables seamless connectivity in public places such as theaters, airports, and restaurants, ensuring users never miss out on important conversations and entertainment.

World’s First Auracast Assistant for Hearing Aids

GN is also launching the first-ever Auracast Assistant within the ReSound Smart 3D app, allowing users to effortlessly connect to Auracast audio streams with a single tap. This simplifies accessibility and ensures compatibility even with devices that do not yet feature built-in Auracast support.

A Future of Seamless Hearing Innovation

Brian Dam Pedersen, Chief Technology Officer at GN, emphasized the company’s mission: “With ReSound Vivia, we are redefining how AI enhances the hearing experience. Our Intelligent Focus feature mirrors natural human behavior, allowing AI to prioritize sounds based on the direction users are looking. This delivers an intuitive, effortless hearing experience that feels natural and seamless. And this is just the beginning—we are committed to applying this cutting-edge technology across all GN innovations.”

Designed for Professionals and Users Alike

GN has also introduced improvements tailored for hearing care professionals, including enhanced fitting software, optimized dome and receiver alignment, and exchangeable microphone filters to improve hygiene and device longevity. These enhancements streamline clinic workflows, improve fitting accuracy, and enhance overall user satisfaction.

Availability and Color Options

The ReSound Vivia hearing aids will be available in microRIE rechargeable and two non-rechargeable RIE models, including a CROS model for users with unilateral hearing loss. The elegant new color lineup includes the modern Navy Blue and Red options.

ReSound Savi will be available in a miniRIE rechargeable model and two non-rechargeable RIE models, offering five stylish colors.

Both ReSound Vivia and ReSound Savi will launch in the United States and Germany on February 20, with additional markets to follow.